Laparoscopic hyperthermic intraperitoneal chemotherapy as adjuvant modality following radical surgery for advanced rectal cancer a new look to an old problem

Hepato-Gastroenterology

Volumn 57, Issue 97, 2010, Pages 73-75

  Lygidakis, N J ^a   Patil, Anjali ^a   Giannoulis, Kleanthis ^a   Fukuda, Tadaomi ^a   Kumar, Rohit ^a  

^a Medical Centre Psychiko   (Greece)

Author keywords

Adjuvant chemotherapy; HIPEC; Hyperthermic chemotherapy; Intraperitoneal chemotherapy; Laparoscopy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN BLOOD VESSEL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INSTILLATION, DRUG; LAPAROSCOPY; MALE; MIDDLE AGED; PERITONEAL CAVITY; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952103215     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma; N Engl J Med. 1991 324(11):709-1159
2. Takayuki Akasu, Yoshihiro Moriya, Yasuo Ohashi, Shigeaki Yoshida, Kuniaki Shirao, Susumu Kodaira for the National Surgical Adjuvant Study of Colorectal Cancer: Adjuvant Chemotherapy with Uracil-Tegafur for Pathological Stage III Rectal Cancer after Mesorectal Excision with Selective Lateral Pelvic Lymphadenectomy: A Multicenter Randomised Controlled Trial; Japanese Journal of Clinical Oncology 2006 36(4):237-244.
3. Rebecca L. Siegel, Ahmedin Jemal and Elizabeth M. Ward: Cancer Epidemiology Biomarkers & Prevention 18, 1695, June 1, 2009. doi: 10.1158/1055-9965.EPI-09-0186; Increase in Incidence of Colorectal Cancer Among Young Men and Women in the United States; © 2009 American Association for Cancer Research
4. J Ferlay, P Autier, M Boniol, M Heanue, M Colombet and P Boyle: Estimates of the cancer incidence and mortality in Europe in 2006; Annals of Oncology 2007 18(3):581-585
5. www.doh.state.fl.us/Disease-Ctrl/epi/cancer/Color-ectal-Report. Bureau of epidemiology. Colorectal cancer in Florida 2005.
6. Xiao Cheng Wu, Vivien W. Chen, Brooke Steele, Bernado Ruiz, P, John Fulto, Lihua Liu, Susan E. Carozz, Robert Greenlee: Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States; Cancer 2001; 92: 1992-1997
7. Annika Sjövall, Fredrik Granath, Björn Cedermark, Bengt Glimelius and Torbjörn Holm: Loco-regional Recurrence of Colon Cancer; Annals of Surgical Oncology 2007 14:432-440
8. Vic J. Verwaal, MD, Henk Boot, MD, PhD, Berthe M. P. Aleman, MD, Harm van Tinteren, MSc and Frans A. N. Zoetmulder, MD, PhD: Recurrences after Peritoneal Carcinomatosis of Colorectal Origin Treated by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Location, Treatment, and Outcome; Annals of Surgical Oncology 2004 11:375-379.
9. Verwaal VJ, van Ruth S, de Bree et al: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis from colorectal cancer; J Clin Oncol 2003 21 (20): 3737-43.
10. Verwaal VJ, Bruin J et al: 8 year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer; Ann Surg Ongol 2008 15(9)2426-2432
11. Perry Shen, MD, Jason Hawksworth, MD, James Lovato, PhD, Brian W. Loggie, MD, Kim R. Geisinger, MD, Ronald A. Fleming, PharmD and Edward A. Levine, MD: Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C for Peritoneal Carcinomatosis from Nonappendiceal Colorectal Carcinoma; Annals of Surgical Oncology 2004 11:178-186.
12. Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchai JM et al: Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin; J Clin Oncol. 2009 10; 27 (5): 681-685
13. Beverly A. Teicher, Charles D. Kowal, Katherine A. Kennedy and Alan C. Sartorelli: Enhancement by Hyperthermia of the in Vitro Cytotoxicity of Mitomycin C toward Hypoxic Tumor Cells; Cancer Research 1981 41, 1096-1099. (Pubitemid 11136367)
14. Rankovic VI, Masirevic VP, Pavlov MJ, Ceranic MS, Milenkovic MG, Simic AP, Kecmanovic DM: Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy; Hepatogastroenterogoly 2007 Mar; 54(74):364-366